Pfizer Inc. said on Monday it would acquire Array Biopharma Inc for $10.64-billion in cash, giving it access to the target’s approved drugs for skin cancer and the targeted cancer medicines in its pipeline.
The offer of $48 per Array share represents a premium of about 62 per cent to the stock’s close on Friday. Array’s shares surged 56 per cent in light premarket trade.The U.S. Food and Drug Administration last year approved Array’s oral combination treatment for use in patients with the deadliest form of skin cancer.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
NDP promise to expand universal health care, starting with national drug planThe federal NDP says if it is elected this fall it will expand Canada's health-care system, starting with fast-tracking a universal drug plan to ensure a late 2020 start date. You can’t start something sooner that provinces haven’t signed up for. Very naive promise on NDP ‘s part. What would be more realistic is helping people without drug coverage now. The feds can do that immediately, but the Liberals prefer to make it an election issue. cdnpoli Explain to me why Gov healthcare plans always start with drug companies? (don't worry I already know the answer) Why not start with a national nutrition and fitness program? Oh right my bad.. that might discriminate against the twinkie addicts! That is a very nice hat.
Source: CTVNews - 🏆 1. / 99 Read more »